Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 17919499)

  • 1. The effect of statins in colorectal cancer is mediated through the bone morphogenetic protein pathway.
    Kodach LL; Bleuming SA; Peppelenbosch MP; Hommes DW; van den Brink GR; Hardwick JC
    Gastroenterology; 2007 Oct; 133(4):1272-81. PubMed ID: 17919499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcriptome sequencing analysis reveals unique and shared antitumor effects of three statins in pancreatic cancer.
    Chen C; Wu H; Kong D; Xu Y; Zhang Z; Chen F; Zou L; Li Z; Shui J; Luo H; Liu SH; Yu J; Wang K; Brunicardi FC
    Oncol Rep; 2020 Dec; 44(6):2569-2580. PubMed ID: 33125137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. YAP transcriptionally regulates COX-2 expression and GCCSysm-4 (G-4), a dual YAP/COX-2 inhibitor, overcomes drug resistance in colorectal cancer.
    Li W; Cao Y; Xu J; Wang Y; Li W; Wang Q; Hu Z; Hao Y; Hu L; Sun Y; Xu G; Ao G
    J Exp Clin Cancer Res; 2017 Oct; 36(1):144. PubMed ID: 29037225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autophagy inhibitors increase the susceptibility of KRAS-mutant human colorectal cancer cells to a combined treatment of 2-deoxy-D-glucose and lovastatin.
    Huang XM; Huang JJ; Du JJ; Zhang N; Long Z; Yang Y; Zhong FF; Zheng BW; Shen YF; Huang Z; Qin X; Chen JH; Lin QY; Lin WJ; Ma WZ
    Acta Pharmacol Sin; 2021 Nov; 42(11):1875-1887. PubMed ID: 33608672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simvastatin prevents triple-negative breast cancer metastasis in pre-clinical models through regulation of FOXO3a.
    Wolfe AR; Debeb BG; Lacerda L; Larson R; Bambhroliya A; Huang X; Bertucci F; Finetti P; Birnbaum D; Van Laere S; Diagaradjan P; Ruffell B; Trenton NJ; Chu K; Hittelman W; Diehl M; Levental I; Ueno NT; Woodward WA
    Breast Cancer Res Treat; 2015 Dec; 154(3):495-508. PubMed ID: 26590814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Weak response of bovine hepcidin induction to iron through decreased expression of Smad4.
    Sadakane H; Matsumura M; Murakami M; Itoyama E; Shimokawa F; Sakota S; Yoshioka H; Kawabata H; Matsui T; Funaba M
    FASEB J; 2023 Nov; 37(11):e23243. PubMed ID: 37800888
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dantrolene and coenzyme Q10 as a suggested combination therapy to statin-induced myopathy in high fat diet rats: A possible interference with ROS/ TGF-β / Smad4 signaling pathway.
    Zakaria S; Elshazly AM; Alaa R; Elsebaey S
    Toxicol Appl Pharmacol; 2024 Apr; 485():116900. PubMed ID: 38508403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-cancer potential of MAPK pathway inhibition in paragangliomas-effect of different statins on mouse pheochromocytoma cells.
    Fliedner SM; Engel T; Lendvai NK; Shankavaram U; Nölting S; Wesley R; Elkahloun AG; Ungefroren H; Oldoerp A; Lampert G; Lehnert H; Timmers H; Pacak K
    PLoS One; 2014; 9(5):e97712. PubMed ID: 24846270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone morphogenetic protein and Notch signalling crosstalk in poor-prognosis, mesenchymal-subtype colorectal cancer.
    Irshad S; Bansal M; Guarnieri P; Davis H; Al Haj Zen A; Baran B; Pinna CMA; Rahman H; Biswas S; Bardella C; Jeffery R; Wang LM; East JE; Tomlinson I; Lewis A; Leedham SJ
    J Pathol; 2017 Jun; 242(2):178-192. PubMed ID: 28299802
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BMP Stimulation Differentially Affects Phosphorylation and Protein Stability of β-Catenin in Breast Cancer Cell Lines.
    Ilhan M; Hastar N; Kampfrath B; Spierling DN; Jatzlau J; Knaus P
    Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38731813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutated CEACAMs Disrupt Transforming Growth Factor Beta Signaling and Alter the Intestinal Microbiome to Promote Colorectal Carcinogenesis.
    Gu S; Zaidi S; Hassan MI; Mohammad T; Malta TM; Noushmehr H; Nguyen B; Crandall KA; Srivastav J; Obias V; Lin P; Nguyen BN; Yao M; Yao R; King CH; Mazumder R; Mishra B; Rao S; Mishra L
    Gastroenterology; 2020 Jan; 158(1):238-252. PubMed ID: 31585122
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aggressive melanoma cells escape from BMP7-mediated autocrine growth inhibition through coordinated Noggin upregulation.
    Hsu MY; Rovinsky SA; Lai CY; Qasem S; Liu X; How J; Engelhardt JF; Murphy GF
    Lab Invest; 2008 Aug; 88(8):842-55. PubMed ID: 18560367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification and analysis of the molecular targets of statins in colorectal cancer.
    Firouzjaei AA; Mahmoudi A; Almahmeed W; Teng Y; Kesharwani P; Sahebkar A
    Pathol Res Pract; 2024 Apr; 256():155258. PubMed ID: 38522123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of a nitroaromatic nannocystin with potent in vivo anticancer activity against colorectal cancer by targeting AKT1.
    Zhang H; Xie F; Yuan XY; Dai XT; Tian YF; Sun MM; Yu SQ; Cai JY; Sun B; Zhang WC; Shan CL
    Acta Pharmacol Sin; 2024 May; 45(5):1044-1059. PubMed ID: 38326625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Black Raspberries Suppress Colorectal Cancer by Enhancing Smad4 Expression in Colonic Epithelium and Natural Killer Cells.
    Huang YW; Lin CW; Pan P; Shan T; Echeveste CE; Mo YY; Wang HT; Aldakkak M; Tsai S; Oshima K; Yearsley M; Xiao J; Cao H; Sun C; Du M; Bai W; Yu J; Wang LS
    Front Immunol; 2020; 11():570683. PubMed ID: 33424832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of the bone morphogenetic protein pathway suppresses tumor growth through downregulation of epidermal growth factor receptor in MEK/ERK-dependent colorectal cancer.
    Shimizu S; Kondo J; Onuma K; Coppo R; Ota K; Kamada M; Harada Y; Tanaka Y; Nakazawa MA; Tamada Y; Okuno Y; Kawada K; Obama K; Coffey RJ; Fujiwara Y; Inoue M
    Cancer Sci; 2023 Sep; 114(9):3636-3648. PubMed ID: 37357017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel effects of simvastatin on uterine fibroid tumors: in vitro and patient-derived xenograft mouse model study.
    Borahay MA; Vincent K; Motamedi M; Sbrana E; Kilic GS; Al-Hendy A; Boehning D
    Am J Obstet Gynecol; 2015 Aug; 213(2):196.e1-8. PubMed ID: 25840272
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of SETD2 aggravates colorectal cancer progression caused by SMAD4 deletion through the RAS/ERK signalling pathway.
    Ma C; Liu M; Feng W; Rao H; Zhang W; Liu C; Xu Y; Wang Z; Teng Y; Yang X; Ni L; Xu J; Gao WQ; Lu B; Li L
    Clin Transl Med; 2023 Nov; 13(11):e1475. PubMed ID: 37962020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of tumor-derived SMAD4 enhances primary tumor growth but not metastasis following BMP4 signalling.
    Chi LH; Redfern AD; Roslan S; Street IP; Burrows AD; Anderson RL
    Cell Commun Signal; 2024 Apr; 22(1):248. PubMed ID: 38689334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Daunorubicin induces GLI1‑dependent apoptosis in colorectal cancer cell lines.
    Kim BR; Kim DY; Tran NL; Kim BG; Lee SI; Kang SH; Min BY; Hur W; Oh SC
    Int J Oncol; 2024 Jun; 64(6):. PubMed ID: 38757343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.